Atricure appoints shlomi nachman to the board of directors

Mason, ohio--(business wire)--atricure, inc. (nasdaq: atrc), a leading innovator in surgical treatments and therapies for atrial fibrillation (afib), left atrial appendage (laa) management and post-operative pain management, today announced it appointed shlomi nachman to its board of directors. mr. nachman's long and distinguished career in the medical device industry has placed him at the forefront of new market development and growth, serving most recently as company group chairman within joh.
ATRC Ratings Summary
ATRC Quant Ranking